ATE488508T1 - Verfahren zur herstellung von irbesartan und zwischenprodukte davon - Google Patents

Verfahren zur herstellung von irbesartan und zwischenprodukte davon

Info

Publication number: ATE488508T1
Authority: AT; Austria
Prior art keywords: intermediate products; irbesartan; producing; producing irbesartan; products
Prior art date: 2004-08-23

Application number

AT05791492T

Other languages

English (en)

Inventor

Edgar Miranda

Cornelis Vlaar

Jingyang Zhu

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-23

Filing date

2005-08-23

Publication date

2010-12-15

2005-08-23 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

2010-12-15 Application granted granted Critical

2010-12-15 Publication of ATE488508T1 publication Critical patent/ATE488508T1/de

Links

239000002947 C09CA04 - Irbesartan Substances 0.000 title 1
239000013067 intermediate product Substances 0.000 title 1
YCPOHTHPUREGFM-UHFFFAOYSA-N irbesartan Chemical compound O=C1N(CC=2C=CC(=CC=2)C=2C(=CC=CC=2)C=2[N]N=NN=2)C(CCCC)=NC21CCCC2 YCPOHTHPUREGFM-UHFFFAOYSA-N 0.000 title 1
229960002198 irbesartan Drugs 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

AT05791492T 2004-08-23 2005-08-23 Verfahren zur herstellung von irbesartan und zwischenprodukte davon ATE488508T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US60360604P	2004-08-23	2004-08-23
PCT/US2005/029879 WO2006023889A2 (en)	2004-08-23	2005-08-23	A method for preparing irbesartan and intermediates thereof

Publications (1)

Publication Number	Publication Date
ATE488508T1 true ATE488508T1 (de)	2010-12-15

Family

ID=35968277

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05791492T ATE488508T1 (de)	2004-08-23	2005-08-23	Verfahren zur herstellung von irbesartan und zwischenprodukte davon

Country Status (20)

Country	Link
US (2)	US7211676B2 (de)
EP (1)	EP1781627B1 (de)
JP (1)	JP5203703B2 (de)
KR (1)	KR101252309B1 (de)
CN (1)	CN101006064B (de)
AR (1)	AR050709A1 (de)
AT (1)	ATE488508T1 (de)
AU (1)	AU2005277162B2 (de)
BR (1)	BRPI0514584A (de)
CA (2)	CA2754633A1 (de)
DE (1)	DE602005024819D1 (de)
ES (1)	ES2357393T3 (de)
IL (1)	IL181464A (de)
MX (1)	MX2007002030A (de)
NO (1)	NO20071254L (de)
PE (1)	PE20060650A1 (de)
RU (1)	RU2388753C2 (de)
TW (1)	TWI346108B (de)
WO (1)	WO2006023889A2 (de)
ZA (1)	ZA200701363B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1918288A1 (de)	2006-11-02	2008-05-07	Cadila Pharmaceuticals Limited	Neues und verbessertes Verfahren für die Zubereitung von Irbesartan, einem Angiotensin-II Rezeptorantagonisten für die Behandlung von Bluthochdruck
GB0700993D0 (en) *	2007-01-18	2007-02-28	Rainbow Engineering Services	Novel compounds
CN101657442A (zh) *	2007-03-06	2010-02-24	阿克塔维什集团Ptc公司	改进的制备依贝沙坦的方法
SI22488A (sl) *	2007-04-24	2008-10-31	Krka, Tovarna Zdravil, D.D., Novo Mesto	Kristalni 1-(cikloheksiloksikarboniloksi)etil 1-((2'-cianobifenil-4-il)metil) - 2-etoksi-1h-benz(d)imidazol -7-karboksilat in proces za njegovo pripravo
HUP0900788A2 (en) *	2009-12-16	2011-11-28	Sanofi Aventis	Process for producing 4-bromomethyl-biphenyl derivatives
AU2011225122B8 (en) *	2010-03-12	2013-12-12	Nippon Soda Co., Ltd.	Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative
CN102807564A (zh) *	2012-08-30	2012-12-05	珠海润都制药股份有限公司	厄贝沙坦的制备方法
CN102898420B (zh) *	2012-09-10	2014-10-29	珠海保税区丽珠合成制药有限公司	一种厄贝沙坦的合成路线及制备方法
CN103497178B (zh) *	2013-09-27	2015-04-08	中国药科大学	厄贝沙坦瑞格列奈共无定型物
CN104744303B (zh) *	2015-02-15	2017-06-23	北京欣奕华科技有限公司	2‑r‑4’‑溴甲基联苯及其制备方法
CN108164434A (zh) *	2017-12-27	2018-06-15	安徽太主科技发展有限公司	一种低成本4′-溴甲基-2-氰基联苯的制备方法
US11655220B2 (en)	2020-10-22	2023-05-23	Hetero Labs Limited	Process for the preparation of angiotensin II receptor blockers

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3340595A1 (de) *	1983-11-10	1985-05-23	Hoechst Ag, 6230 Frankfurt	Imidazolinone, verfahren zu ihrer herstellung und ihre verwendung im pflanzenschutz
US5270317A (en) *	1990-03-20	1993-12-14	Elf Sanofi	N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
TW201738B (de) *	1990-03-20	1993-03-11	Sanofi Co
US5541209A (en)	1994-08-22	1996-07-30	Bristol-Myers Squibb Company	Method of treating or preventing cardiac arrhythmia employing an N-substituted heterocyclic derivative
FR2725987B1 (fr) *	1994-10-19	1997-01-10	Sanofi Sa	Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive
US5994348A (en)	1995-06-07	1999-11-30	Sanofi	Pharmaceutical compositions containing irbesartan
JP3003030B2 (ja) *	1997-05-26	2000-01-24	武田薬品工業株式会社	アミノベンゼン化合物の製造法
FR2766821A1 (fr)	1997-07-29	1999-02-05	Sanofi Sa	Derives de 1,3-oxazolinyl-biphenyle, leur procede de preparation et leur utilisation comme intermediaires de synthese
US6162922A (en) *	1998-01-30	2000-12-19	Bristol-Myers Squibb Co.	Method for preparing N-substituted heterocyclic derivatives using a phase-transfer catalyst
FR2780403B3 (fr) *	1998-06-24	2000-07-21	Sanofi Sa	Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
CN100418962C (zh) *	2002-10-28	2008-09-17	南京长澳医药科技有限公司	一种厄贝沙坦合成工艺
WO2004065383A2 (en) *	2003-01-16	2004-08-05	Teva Pharmaceutical Industries Ltd.	Novel synthesis of irbesartan

2005
- 2005-08-19 TW TW094128424A patent/TWI346108B/zh not_active IP Right Cessation
- 2005-08-22 US US11/209,000 patent/US7211676B2/en not_active Expired - Lifetime
- 2005-08-22 AR ARP050103520A patent/AR050709A1/es not_active Application Discontinuation
- 2005-08-23 WO PCT/US2005/029879 patent/WO2006023889A2/en not_active Ceased
- 2005-08-23 AT AT05791492T patent/ATE488508T1/de not_active IP Right Cessation
- 2005-08-23 EP EP05791492A patent/EP1781627B1/de not_active Expired - Lifetime
- 2005-08-23 KR KR1020077004208A patent/KR101252309B1/ko not_active Expired - Fee Related
- 2005-08-23 ES ES05791492T patent/ES2357393T3/es not_active Expired - Lifetime
- 2005-08-23 JP JP2007530039A patent/JP5203703B2/ja not_active Expired - Fee Related
- 2005-08-23 BR BRPI0514584-8A patent/BRPI0514584A/pt not_active IP Right Cessation
- 2005-08-23 CA CA2754633A patent/CA2754633A1/en not_active Abandoned
- 2005-08-23 CA CA002578409A patent/CA2578409A1/en not_active Withdrawn
- 2005-08-23 RU RU2007109330/04A patent/RU2388753C2/ru not_active IP Right Cessation
- 2005-08-23 PE PE2005000967A patent/PE20060650A1/es not_active Application Discontinuation
- 2005-08-23 CN CN2005800286578A patent/CN101006064B/zh not_active Expired - Fee Related
- 2005-08-23 MX MX2007002030A patent/MX2007002030A/es active IP Right Grant
- 2005-08-23 DE DE602005024819T patent/DE602005024819D1/de not_active Expired - Lifetime
- 2005-08-23 AU AU2005277162A patent/AU2005277162B2/en not_active Ceased
2007
- 2007-02-15 ZA ZA200701363A patent/ZA200701363B/xx unknown
- 2007-02-20 IL IL181464A patent/IL181464A/en not_active IP Right Cessation
- 2007-03-07 NO NO20071254A patent/NO20071254L/no not_active Application Discontinuation
- 2007-03-20 US US11/688,635 patent/US7365208B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
IL181464A0 (en)	2007-07-04
CN101006064B (zh)	2011-01-26
US20070167634A1 (en)	2007-07-19
US7365208B2 (en)	2008-04-29
WO2006023889A3 (en)	2006-09-08
EP1781627A4 (de)	2009-09-02
TW200619205A (en)	2006-06-16
PE20060650A1 (es)	2006-07-09
KR101252309B1 (ko)	2013-04-08
MX2007002030A (es)	2007-03-28
EP1781627A2 (de)	2007-05-09
WO2006023889A2 (en)	2006-03-02
AU2005277162A1 (en)	2006-03-02
AR050709A1 (es)	2006-11-15
ZA200701363B (en)	2008-06-25
US20060041147A1 (en)	2006-02-23
JP5203703B2 (ja)	2013-06-05
HK1098157A1 (en)	2007-07-13
CN101006064A (zh)	2007-07-25
US7211676B2 (en)	2007-05-01
RU2388753C2 (ru)	2010-05-10
CA2578409A1 (en)	2006-03-02
TWI346108B (en)	2011-08-01
CA2754633A1 (en)	2006-03-02
NO20071254L (no)	2007-03-22
AU2005277162B2 (en)	2010-12-16
EP1781627B1 (de)	2010-11-17
KR20070045275A (ko)	2007-05-02
BRPI0514584A (pt)	2008-06-17
IL181464A (en)	2011-08-31
ES2357393T3 (es)	2011-04-26
JP2008510819A (ja)	2008-04-10
RU2007109330A (ru)	2008-09-27
DE602005024819D1 (de)	2010-12-30

Legal Events

Date	Code	Title	Description
2011-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE602006020386D1 (de)	2011-04-14	Duraimplantat und Verfahren zu seiner Herstellung
EP1833992A4 (de)	2010-01-20	Pcv2-immunogene zusammensetzungen und verfahren zur herstellung solcher zusammensetzungen
ATE408609T1 (de)	2008-10-15	Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden
EP1877175A4 (de)	2012-08-15	Vorrichtung und verfahren zur herstellung von radiopharmazeutika
DE602005019848D1 (de)	2010-04-22	Verfahren zur herstellung von tad- getrocknetem ti
DE602005015473D1 (de)	2009-08-27	Verfahren und mittel zur herstellung von hyaluronan
DE602004023910D1 (de)	2009-12-17	Verbundmaterial und Verfahren zu seiner Herstellung
ATE408604T1 (de)	2008-10-15	Verfahren zur herstellung von 1-alkyl-3- phenyluracilen
DE502006005961D1 (de)	2010-03-11	Endoskop und Verfahren zu seiner Herstellung
ATE489015T1 (de)	2010-12-15	Verfahren zur herstellung von verschlüssen
DE602004028894D1 (de)	2010-10-14	Sensor und Verfahren zur Herstellung desselben
ATE457969T1 (de)	2010-03-15	Verfahren zur herstellung von aloe-emodin
ATE399157T1 (de)	2008-07-15	Verfahren zur herstellung von telmisartan
ATE429820T1 (de)	2009-05-15	Durchlüftetes nahrungsmittel und verfahren zu seiner herstellung
ATE488508T1 (de)	2010-12-15	Verfahren zur herstellung von irbesartan und zwischenprodukte davon
ATE461919T1 (de)	2010-04-15	Verfahren zur herstellung von montelukast und zwischenprodukte dafür
DE502006009351D1 (de)	2011-06-01	Feinteiliges azopigment und verfahren zu seiner herstellung
ATE406372T1 (de)	2008-09-15	Verfahren zur herstellung von 3-o-geschützten morphinonen und 3-o-geschützten morphinondienolcarboxylaten
ATE444303T1 (de)	2009-10-15	Verfahren zur herstellung von ferrisuccinylcasein
ATE427040T1 (de)	2009-04-15	Verfahren zur herstellung von nahrungsmitteln und so hergestelltes nahrungsmittel
DE102005032999A8 (de)	2006-08-10	Sensor und Verfahren zur Herstellung desselben
ATE549314T1 (de)	2012-03-15	Verfahren zur herstellung von 4-aminochinazolinen
DE602005016377D1 (de)	2009-10-15	Geformter holzartikel und verfahren zur herstellung des geformten holzartikels
EP1907468A4 (de)	2010-11-17	Verfahren zur herstellung von nanoverbundstoffen und nanoverbundstoffe
DE602007013830D1 (de)	2011-05-26	Verfahren und System zur Herstellung von Gussformen